ID   SYVN1_HUMAN             Reviewed;         617 AA.
AC   Q86TM6; Q8N3K3; Q8N6E8; Q96JL5; Q96PK3;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=E3 ubiquitin-protein ligase synoviolin;
DE            EC=2.3.2.27;
DE   AltName: Full=RING-type E3 ubiquitin transferase synoviolin {ECO:0000305};
DE   AltName: Full=Synovial apoptosis inhibitor 1;
DE   Flags: Precursor;
GN   Name=SYVN1; Synonyms=HRD1, KIAA1810;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF CYS-329, INDUCTION BY ER STRESS,
RP   AUTOUBIQUITINATION, AND PATHWAY.
RX   PubMed=12459480; DOI=10.1016/S0014-5793(02)03660-8;
RA   Kaneko M., Ishiguro M., Niinuma Y., Uesugi M., Nomura Y.;
RT   "Human HRD1 protects against ER stress-induced apoptosis through ER-
RT   associated degradation.";
RL   FEBS Lett. 532:147-152(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND AUTOUBIQUITINATION.
RX   PubMed=12646171; DOI=10.1016/S0006-291X(03)00279-1;
RA   Nadav E., Shmueli A., Barr H., Gonen H., Ciechanover A., Reiss Y.;
RT   "A novel mammalian endoplasmic reticulum ubiquitin ligase homologous
RT   to the yeast Hrd1.";
RL   Biochem. Biophys. Res. Commun. 303:91-97(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND AUTOUBIQUITINATION.
RC   TISSUE=Articular cartilage;
RX   PubMed=12975321; DOI=10.1101/gad.1096603;
RA   Amano T., Yamasaki S., Yagishita N., Tsuchimochi K., Shin H.,
RA   Kawahara K., Aratani S., Fujita H., Zhang L., Ikeda R., Fujii R.,
RA   Miura N., Komiya S., Nishioka K., Maruyama I., Fukamizu A.,
RA   Nakajima T.;
RT   "Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor
RT   for arthropathy.";
RL   Genes Dev. 17:2436-2449(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, INDUCTION BY ER
RP   STRESS, LACK OF GLYCOSYLATION, SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=14593114; DOI=10.1074/jbc.M307453200;
RA   Kikkert M., Doolman R., Dai M., Avner R., Hassink G., van Voorden S.,
RA   Thanedar S., Roitelman J., Chau V., Wiertz E.;
RT   "Human HRD1 is an E3 ubiquitin ligase involved in degradation of
RT   proteins from the endoplasmic reticulum.";
RL   J. Biol. Chem. 279:3525-3534(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, HOMODIMERIZATION, INTERACTION WITH VCP; HERPUD1 AND DERL1,
RP   IDENTIFICATION IN A COMPLEX WITH HERPUD1; VIMP AND DERL1, AND PATHWAY.
RX   PubMed=16289116; DOI=10.1016/j.jmb.2005.10.020;
RA   Schulze A., Standera S., Buerger E., Kikkert M., van Voorden S.,
RA   Wiertz E., Koning F., Kloetzel P.-M., Seeger M.;
RT   "The ubiquitin-domain protein HERP forms a complex with components of
RT   the endoplasmic reticulum associated degradation pathway.";
RL   J. Mol. Biol. 354:1021-1027(2005).
RN   [9]
RP   INTERACTION WITH VCP, AND SUBCELLULAR LOCATION.
RX   PubMed=16186510; DOI=10.1073/pnas.0505006102;
RA   Ye Y., Shibata Y., Kikkert M., van Voorden S., Wiertz E.,
RA   Rapoport T.A.;
RT   "Recruitment of the p97 ATPase and ubiquitin ligases to the site of
RT   retrotranslocation at the endoplasmic reticulum membrane.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:14132-14138(2005).
RN   [10]
RP   IDENTIFICATION IN A COMPLEX WITH DERL2 AND SEL1L, AND INTERACTION WITH
RP   SEL1L.
RX   PubMed=16186509; DOI=10.1073/pnas.0505014102;
RA   Lilley B.N., Ploegh H.L.;
RT   "Multiprotein complexes that link dislocation, ubiquitination, and
RT   extraction of misfolded proteins from the endoplasmic reticulum
RT   membrane.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:14296-14301(2005).
RN   [11]
RP   FUNCTION, AND PATHWAY.
RX   PubMed=17059562; DOI=10.1111/j.1471-4159.2006.04155.x;
RA   Omura T., Kaneko M., Okuma Y., Orba Y., Nagashima K., Takahashi R.,
RA   Fujitani N., Matsumura S., Hata A., Kubota K., Murahashi K.,
RA   Uehara T., Nomura Y.;
RT   "A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a
RT   substrate of Parkin.";
RL   J. Neurochem. 99:1456-1469(2006).
RN   [12]
RP   FUNCTION, AND PATHWAY.
RX   PubMed=16847254; DOI=10.1073/pnas.0604816103;
RA   Arteaga M.F., Wang L., Ravid T., Hochstrasser M., Canessa C.M.;
RT   "An amphipathic helix targets serum and glucocorticoid-induced kinase
RT   1 to the endoplasmic reticulum-associated ubiquitin-conjugation
RT   machinery.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:11178-11183(2006).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH TP53.
RX   PubMed=17170702; DOI=10.1038/sj.emboj.7601490;
RA   Yamasaki S., Yagishita N., Sasaki T., Nakazawa M., Kato Y.,
RA   Yamadera T., Bae E., Toriyama S., Ikeda R., Zhang L., Fujitani K.,
RA   Yoo E., Tsuchimochi K., Ohta T., Araya N., Fujita H., Aratani S.,
RA   Eguchi K., Komiya S., Maruyama I., Higashi N., Sato M., Senoo H.,
RA   Ochi T., Yokoyama S., Amano T., Kim J., Gay S., Fukamizu A.,
RA   Nishioka K., Tanaka K., Nakajima T.;
RT   "Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident
RT   ubiquitin ligase 'Synoviolin'.";
RL   EMBO J. 26:113-122(2007).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH HTT.
RX   PubMed=17141218; DOI=10.1016/j.yexcr.2006.10.031;
RA   Yang H., Zhong X., Ballar P., Luo S., Shen Y., Rubinsztein D.C.,
RA   Monteiro M.J., Fang S.;
RT   "Ubiquitin ligase Hrd1 enhances the degradation and suppresses the
RT   toxicity of polyglutamine-expanded huntingtin.";
RL   Exp. Cell Res. 313:538-550(2007).
RN   [15]
RP   INTERACTION WITH UBXN6.
RX   PubMed=18656546; DOI=10.1016/j.biocel.2008.06.008;
RA   Madsen L., Andersen K.M., Prag S., Moos T., Semple C.A., Seeger M.,
RA   Hartmann-Petersen R.;
RT   "Ubxd1 is a novel co-factor of the human p97 ATPase.";
RL   Int. J. Biochem. Cell Biol. 40:2927-2942(2008).
RN   [16]
RP   INTERACTION WITH ERLEC1; HSPA5; OS9 AND SEL1L.
RX   PubMed=18502753; DOI=10.1074/jbc.M709336200;
RA   Hosokawa N., Wada I., Nagasawa K., Moriyama T., Okawa K., Nagata K.;
RT   "Human XTP3-B forms an endoplasmic reticulum quality control scaffold
RT   with the HRD1-SEL1L ubiquitin ligase complex and BiP.";
RL   J. Biol. Chem. 283:20914-20924(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-613, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [18]
RP   INTERACTION WITH ERLEC1; OS9 AND SEL1L.
RX   PubMed=18264092; DOI=10.1038/ncb1689;
RA   Christianson J.C., Shaler T.A., Tyler R.E., Kopito R.R.;
RT   "OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L
RT   ubiquitin ligase complex for ERAD.";
RL   Nat. Cell Biol. 10:272-282(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-613, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   INTERACTION WITH BAG6.
RX   PubMed=21636303; DOI=10.1016/j.molcel.2011.05.010;
RA   Wang Q., Liu Y., Soetandyo N., Baek K., Hegde R., Ye Y.;
RT   "A ubiquitin ligase-associated chaperone holdase maintains
RT   polypeptides in soluble states for proteasome degradation.";
RL   Mol. Cell 42:758-770(2011).
RN   [23]
RP   FUNCTION IN ERAD PATHWAY, AND PATHWAY.
RX   PubMed=22607976; DOI=10.1016/j.molcel.2012.04.015;
RA   Sato T., Sako Y., Sho M., Momohara M., Suico M.A., Shuto T.,
RA   Nishitoh H., Okiyoneda T., Kokame K., Kaneko M., Taura M., Miyata M.,
RA   Chosa K., Koga T., Morino-Koga S., Wada I., Kai H.;
RT   "STT3B-dependent posttranslational N-glycosylation as a surveillance
RT   system for secretory protein.";
RL   Mol. Cell 47:99-110(2012).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-613, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   FUNCTION, INTERACTION WITH SEL1L, SUBCELLULAR LOCATION, AND PATHWAY.
RX   PubMed=26471130; DOI=10.1111/febs.13564;
RA   Hosokawa N., Wada I.;
RT   "Association of the SEL1L protein transmembrane domain with HRD1
RT   ubiquitin ligase regulates ERAD-L.";
RL   FEBS J. 283:157-172(2016).
CC   -!- FUNCTION: Acts as an E3 ubiquitin-protein ligase which accepts
CC       ubiquitin specifically from endoplasmic reticulum-associated UBC7
CC       E2 ligase and transfers it to substrates, promoting their
CC       degradation. Component of the endoplasmic reticulum quality
CC       control (ERQC) system also called ER-associated degradation (ERAD)
CC       involved in ubiquitin-dependent degradation of misfolded
CC       endoplasmic reticulum proteins. Also promotes the degradation of
CC       normal but naturally short-lived proteins such as SGK. Protects
CC       cells from ER stress-induced apoptosis. Protects neurons from
CC       apoptosis induced by polyglutamine-expanded huntingtin (HTT) or
CC       unfolded GPR37 by promoting their degradation. Sequesters p53/TP53
CC       in the cytoplasm and promotes its degradation, thereby negatively
CC       regulating its biological function in transcription, cell cycle
CC       regulation and apoptosis. {ECO:0000269|PubMed:12459480,
CC       ECO:0000269|PubMed:12646171, ECO:0000269|PubMed:12975321,
CC       ECO:0000269|PubMed:14593114, ECO:0000269|PubMed:16289116,
CC       ECO:0000269|PubMed:16847254, ECO:0000269|PubMed:17059562,
CC       ECO:0000269|PubMed:17141218, ECO:0000269|PubMed:17170702,
CC       ECO:0000269|PubMed:22607976, ECO:0000269|PubMed:26471130}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:12459480, ECO:0000269|PubMed:16289116,
CC       ECO:0000269|PubMed:16847254, ECO:0000269|PubMed:17059562,
CC       ECO:0000269|PubMed:22607976, ECO:0000269|PubMed:26471130}.
CC   -!- SUBUNIT: Homodimer. Interacts with p53/TP53 and HTT. Interacts
CC       with VCP, HERPUD1 and DERL1. Part of a complex containing SYVN1,
CC       HERPUD1, VIMP and DERL1; which probably transfer misfolded
CC       proteins from the ER to VCP. Part of a complex containing SYVN1,
CC       SEL1L and DERL2. Interacts with UBXN6. Interacts (via N-terminal
CC       loop) with SEL1L; recruits ERLEC1 and OS9. May form a complex with
CC       ERLEC1; HSPA5; OS9 AND SEL1L (PubMed:16186509, PubMed:16186510,
CC       PubMed:16289116, PubMed:17141218, PubMed:17170702,
CC       PubMed:18264092, PubMed:18502753, PubMed:18656546,
CC       PubMed:26471130). Interacts with BAG6 (PubMed:21636303).
CC       {ECO:0000269|PubMed:16186509, ECO:0000269|PubMed:16186510,
CC       ECO:0000269|PubMed:16289116, ECO:0000269|PubMed:17141218,
CC       ECO:0000269|PubMed:17170702, ECO:0000269|PubMed:18264092,
CC       ECO:0000269|PubMed:18502753, ECO:0000269|PubMed:18656546,
CC       ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:26471130}.
CC   -!- INTERACTION:
CC       O75460:ERN1; NbExp=2; IntAct=EBI-947849, EBI-371750;
CC       P04637:TP53; NbExp=5; IntAct=EBI-947849, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12459480, ECO:0000269|PubMed:12646171,
CC       ECO:0000269|PubMed:14593114, ECO:0000269|PubMed:16186510,
CC       ECO:0000269|PubMed:26471130}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12459480, ECO:0000269|PubMed:12646171,
CC       ECO:0000269|PubMed:14593114, ECO:0000269|PubMed:16186510}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=b, long;
CC         IsoId=Q86TM6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86TM6-2; Sequence=VSP_023777, VSP_023778;
CC       Name=3; Synonyms=a, short;
CC         IsoId=Q86TM6-3; Sequence=VSP_023778;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in
CC       liver and kidney (at protein level). Up-regulated in synovial
CC       tissues from patients with rheumatoid arthritis (at protein
CC       level). {ECO:0000269|PubMed:12459480, ECO:0000269|PubMed:12646171,
CC       ECO:0000269|PubMed:12975321}.
CC   -!- INDUCTION: By endoplasmic reticulum stress-inducing agents such as
CC       thapsigargin, tunicamycin or brefeldin A, but not by heat shock.
CC       {ECO:0000269|PubMed:12459480, ECO:0000269|PubMed:14593114}.
CC   -!- DOMAIN: The RING-type zinc finger is required for E3 ligase
CC       activity.
CC   -!- PTM: Not N-glycosylated.
CC   -!- PTM: Auto-ubiquitinated. {ECO:0000269|PubMed:12459480,
CC       ECO:0000269|PubMed:12646171, ECO:0000269|PubMed:12975321}.
CC   -!- SIMILARITY: Belongs to the HRD1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB47439.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB085847; BAC24801.1; -; mRNA.
DR   EMBL; AB024690; BAC57449.1; -; mRNA.
DR   EMBL; AF317634; AAL26903.1; -; mRNA.
DR   EMBL; AB058713; BAB47439.1; ALT_INIT; mRNA.
DR   EMBL; AL834262; CAD38937.1; -; mRNA.
DR   EMBL; BC030530; AAH30530.1; -; mRNA.
DR   CCDS; CCDS31605.1; -. [Q86TM6-1]
DR   CCDS; CCDS8097.1; -. [Q86TM6-3]
DR   RefSeq; NP_115807.1; NM_032431.2. [Q86TM6-3]
DR   RefSeq; NP_757385.1; NM_172230.2. [Q86TM6-1]
DR   RefSeq; XP_011543605.1; XM_011545303.2. [Q86TM6-1]
DR   UniGene; Hs.75859; -.
DR   ProteinModelPortal; Q86TM6; -.
DR   SMR; Q86TM6; -.
DR   BioGrid; 124085; 94.
DR   DIP; DIP-43982N; -.
DR   IntAct; Q86TM6; 20.
DR   MINT; MINT-4052103; -.
DR   STRING; 9606.ENSP00000366395; -.
DR   iPTMnet; Q86TM6; -.
DR   PhosphoSitePlus; Q86TM6; -.
DR   BioMuta; SYVN1; -.
DR   DMDM; 134035039; -.
DR   EPD; Q86TM6; -.
DR   MaxQB; Q86TM6; -.
DR   PaxDb; Q86TM6; -.
DR   PeptideAtlas; Q86TM6; -.
DR   PRIDE; Q86TM6; -.
DR   DNASU; 84447; -.
DR   Ensembl; ENST00000294256; ENSP00000294256; ENSG00000162298. [Q86TM6-3]
DR   Ensembl; ENST00000307289; ENSP00000302035; ENSG00000162298. [Q86TM6-2]
DR   Ensembl; ENST00000377190; ENSP00000366395; ENSG00000162298. [Q86TM6-1]
DR   Ensembl; ENST00000526060; ENSP00000436984; ENSG00000162298. [Q86TM6-3]
DR   GeneID; 84447; -.
DR   KEGG; hsa:84447; -.
DR   UCSC; uc001odb.4; human. [Q86TM6-1]
DR   CTD; 84447; -.
DR   DisGeNET; 84447; -.
DR   GeneCards; MIR6751; -.
DR   GeneCards; SYVN1; -.
DR   HGNC; HGNC:20738; SYVN1.
DR   HPA; CAB037030; -.
DR   HPA; HPA005480; -.
DR   HPA; HPA024300; -.
DR   MIM; 608046; gene.
DR   neXtProt; NX_Q86TM6; -.
DR   OpenTargets; ENSG00000162298; -.
DR   PharmGKB; PA128394735; -.
DR   eggNOG; KOG0802; Eukaryota.
DR   eggNOG; COG5243; LUCA.
DR   GeneTree; ENSGT00530000062938; -.
DR   HOGENOM; HOG000294196; -.
DR   HOVERGEN; HBG094015; -.
DR   InParanoid; Q86TM6; -.
DR   KO; K10601; -.
DR   OMA; AMEGHQR; -.
DR   OrthoDB; EOG091G13IJ; -.
DR   PhylomeDB; Q86TM6; -.
DR   TreeFam; TF318635; -.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; SYVN1; human.
DR   GeneWiki; SYVN1; -.
DR   GenomeRNAi; 84447; -.
DR   PRO; PR:Q86TM6; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000162298; -.
DR   CleanEx; HS_SYVN1; -.
DR   ExpressionAtlas; Q86TM6; baseline and differential.
DR   Genevisible; Q86TM6; HS.
DR   GO; GO:0036513; C:Derlin-1 retrotranslocation complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0000836; C:Hrd1p ubiquitin ligase complex; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0000839; C:Hrd1p ubiquitin ligase ERAD-L complex; IMP:UniProtKB.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0051117; F:ATPase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1904264; F:ubiquitin protein ligase activity involved in ERAD pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:1904380; P:endoplasmic reticulum mannose trimming; TAS:Reactome.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IBA:GO_Central.
DR   GO; GO:0036503; P:ERAD pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR032832; E3_lig_synoviolin/Hrd1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR22763:SF161; PTHR22763:SF161; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum;
KW   Membrane; Metal-binding; Phosphoprotein; Reference proteome; Signal;
KW   Stress response; Transferase; Transmembrane; Transmembrane helix;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    617       E3 ubiquitin-protein ligase synoviolin.
FT                                /FTId=PRO_0000280548.
FT   TOPO_DOM     23     41       Lumenal. {ECO:0000255}.
FT   TRANSMEM     42     62       Helical. {ECO:0000255}.
FT   TOPO_DOM     63     98       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     99    119       Helical. {ECO:0000255}.
FT   TOPO_DOM    120    140       Lumenal. {ECO:0000255}.
FT   TRANSMEM    141    161       Helical. {ECO:0000255}.
FT   TOPO_DOM    162    169       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    170    190       Helical. {ECO:0000255}.
FT   TOPO_DOM    191    224       Lumenal. {ECO:0000255}.
FT   TRANSMEM    225    245       Helical. {ECO:0000255}.
FT   TOPO_DOM    246    617       Cytoplasmic. {ECO:0000255}.
FT   ZN_FING     291    330       RING-type; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00175}.
FT   REGION       21     42       Interaction with SEL1L.
FT                                {ECO:0000250|UniProtKB:Q9DBY1}.
FT   REGION      236    270       Interaction with p53/TP53.
FT                                {ECO:0000269|PubMed:17170702}.
FT   COMPBIAS    339    478       Pro-rich.
FT   MOD_RES     613    613       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     127    177       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11347906}.
FT                                /FTId=VSP_023777.
FT   VAR_SEQ     411    411       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:11347906,
FT                                ECO:0000303|PubMed:12459480,
FT                                ECO:0000303|PubMed:14593114,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_023778.
FT   MUTAGEN     329    329       C->S: Abolishes E3 ligase activity.
FT                                {ECO:0000269|PubMed:12459480}.
FT   CONFLICT    145    145       M -> I (in Ref. 1; BAC24801 and 4;
FT                                AAL26903). {ECO:0000305}.
FT   CONFLICT    545    545       E -> G (in Ref. 3; BAC57449).
FT                                {ECO:0000305}.
SQ   SEQUENCE   617 AA;  67685 MW;  B8A6BACBAF9673C1 CRC64;
     MFRTAVMMAA SLALTGAVVA HAYYLKHQFY PTVVYLTKSS PSMAVLYIQA FVLVFLLGKV
     MGKVFFGQLR AAEMEHLLER SWYAVTETCL AFTVFRDDFS PRFVALFTLL LFLKCFHWLA
     EDRVDFMERS PNISWLFHCR IVSLMFLLGI LDFLFVSHAY HSILTRGASV QLVFGFEYAI
     LMTMVLTIFI KYVLHSVDLQ SENPWDNKAV YMLYTELFTG FIKVLLYMAF MTIMIKVHTF
     PLFAIRPMYL AMRQFKKAVT DAIMSRRAIR NMNTLYPDAT PEELQAMDNV CIICREEMVT
     GAKRLPCNHI FHTSCLRSWF QRQQTCPTCR MDVLRASLPA QSPPPPEPAD QGPPPAPHPP
     PLLPQPPNFP QGLLPPFPPG MFPLWPPMGP FPPVPPPPSS GEAVAPPSTS AAALSRPSGA
     ATTTAAGTSA TAASATASGP GSGSAPEAGP APGFPFPPPW MGMPLPPPFA FPPMPVPPAG
     FAGLTPEELR ALEGHERQHL EARLQSLRNI HTLLDAAMLQ INQYLTVLAS LGPPRPATSV
     NSTEETATTV VAAASSTSIP SSEATTPTPG ASPPAPEMER PPAPESVGTE EMPEDGEPDA
     AELRRRRLQK LESPVAH
//
